Shanghai Medicilon Inc - ESG Rating & Company Profile powered by AI
The report of Shanghai Medicilon Inc uses intelligence from across the internet as well as from public documents by Shanghai Medicilon Inc. The assessment of Shanghai Medicilon Inc was assembled by All Street Sevva using leading machine learning. Full Sustainability assessment of Shanghai Medicilon Inc are accessed by signing in.
Shanghai Medicilon Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Shanghai Medicilon Inc | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Shanghai Medicilon Inc have an accelerator or VC vehicle to help deliver innovation?
Does Shanghai Medicilon Inc disclose current and historical energy intensity?
Does Shanghai Medicilon Inc report the average age of the workforce?
Does Shanghai Medicilon Inc reference operational or capital allocation in relation to climate change?
Does Shanghai Medicilon Inc disclose its ethnicity pay gap?
Does Shanghai Medicilon Inc disclose cybersecurity risks?
Does Shanghai Medicilon Inc offer flexible work?
Does Shanghai Medicilon Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Shanghai Medicilon Inc disclose the number of employees in R&D functions?
Does Shanghai Medicilon Inc conduct supply chain audits?
Does Shanghai Medicilon Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Shanghai Medicilon Inc conduct 360 degree staff reviews?
Does Shanghai Medicilon Inc disclose the individual responsible for D&I?
Does Shanghai Medicilon Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Shanghai Medicilon Inc disclose current and / or historical scope 2 emissions?
Does Shanghai Medicilon Inc disclose water use targets?
Does Shanghai Medicilon Inc have careers partnerships with academic institutions?
Did Shanghai Medicilon Inc have a product recall in the last two years?
Does Shanghai Medicilon Inc disclose incidents of discrimination?
Does Shanghai Medicilon Inc allow for Work Councils/Collective Agreements to be formed?
Has Shanghai Medicilon Inc issued a profit warning in the past 24 months?
Does Shanghai Medicilon Inc disclose parental leave metrics?
Does Shanghai Medicilon Inc disclose climate scenario or pathway analysis?
Does Shanghai Medicilon Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Shanghai Medicilon Inc disclose the pay ratio of women to men?
Does Shanghai Medicilon Inc support suppliers with sustainability related research and development?
Does Shanghai Medicilon Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Shanghai Medicilon Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Shanghai Medicilon Inc involved in embryonic stem cell research?
Does Shanghai Medicilon Inc disclose GHG and Air Emissions intensity?
Does Shanghai Medicilon Inc disclose its waste policy?
Does Shanghai Medicilon Inc report according to TCFD requirements?
Does Shanghai Medicilon Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Shanghai Medicilon Inc disclose energy use targets?
Does Shanghai Medicilon Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Shanghai Medicilon Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Shanghai Medicilon Inc
These potential risks are based on the size, segment and geographies of the company.
Shanghai Medicilon Inc., a drug discovery contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally. It offers chemistry services, including medicinal, synthesis, and analytical chemistry services, as well as process development services; and drug formulation services, such as pre-formulation and analytical development services, as well as research on quality control and clinical trial material services. The company also provides biology services comprising recombinant protein, crystallization and structural, discovery biology, computational biology and molecular modeling, and kinase services, as well as prepackaged M9 selenomethionine growth media kits and packages for growing cell culture in IPTG-inducible bacterial expression systems. In addition, it offers pharmacology services, including cancer xenograft, metabolic disease, inflammation and immunological, neurological disorders, and other disease models; services in the areas of in vitro ADME and in vivo pharmacokinetics; and bioanalytical services, such as large and small molecule services. Further, the company provides preclinical services comprising preclinical pharmacokinetic and safety evaluation. Shanghai Medicilon Inc. was founded in 2004 and is headquartered in Shanghai, China.